What Is Metabolic Dysfunction–Associated Steatotic Liver Disease?

JAMA 2026

View at publisher
Authors: Rebecca Voelker
DOI: 10.1001/jama.2025.26689
Cited by: 1
References: 1

Abstract

This JAMA Patient Page describes metabolic dysfunction–associated steatotic liver disease (MASLD) and its risk factors, symptoms and complications, diagnosis, and treatment.

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Drug-Induced Hepatotoxicity and Protection Liver Disease and Transplantation

Publication details

Journal / source
JAMA
Publisher
American Medical Association (AMA)
Volume
335
Issue
19
Pages
1734–1734
Publication date
26 February 2026
Language
EN